J Allergy Clin Immunol Pract 2025 Jan
Dupilumab Use in Patients With Hypereosinophilic Syndromes: A Multicenter Case Series and Review of the Literature.
Related Questions
Dupixent was started for asthma. Eosinophils rose from 880 to 1940 after 6-8 weeks of therapy.
New answer by at Uniformed Services University (December 31, 2025)
I would likely not stop Dupixent. This patient appears to be doing well clinically based on the question stem. I would have liked to see more pre-dupilumab treatment eosinophi...